Cite
Khan A, Woodley C, Radia D, et al. Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center. Hemasphere. 2021;5(7):e611doi: 10.1097/HS9.0000000000000611.
Khan, A., Woodley, C., Radia, D., Mikhaeel, G. N., Brady, J., Garcia, N. C., Harrington, P., O'Sullivan, J., Kordasti, S., Francis, Y., Asirvatham, S., Ali, S., Sriskandarajah, P., Saunders, J., de Lavallade, H., McLornan, D. P., & Harrison, C. N. (2021). Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center. HemaSphere, 5(7), e611. https://doi.org/10.1097/HS9.0000000000000611
Khan, Alesia, et al. "Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center." HemaSphere vol. 5,7 (2021): e611. doi: https://doi.org/10.1097/HS9.0000000000000611
Khan A, Woodley C, Radia D, Mikhaeel GN, Brady J, Garcia NC, Harrington P, O'Sullivan J, Kordasti S, Francis Y, Asirvatham S, Ali S, Sriskandarajah P, Saunders J, de Lavallade H, McLornan DP, Harrison CN. Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center. Hemasphere. 2021 Jun 28;5(7):e611. doi: 10.1097/HS9.0000000000000611. eCollection 2021 Jul. PMID: 34235403; PMCID: PMC8240780.
Copy
Download .nbib